Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewInveready successfully closes Inveready Innvierte Biotech II, its second life sciences fun...
Inveready completes its third venture capital fund with a 4.3x return on capital invested by shareholders
-
NewMikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
-
NewEHDS: A revolution in health data management
The European Health Data Space (EHDS) is conceived as a federated, interoperable, secure and privacy-focused infrastructure, integrating health data generated in all Member States.
-
NewNew technology detects breast cancer relapse up to five years before symptoms appear using...
A study led by Dr. Iñaki Comino-Méndez and Dr. Emilio Alba from the Hospital Universitario Virgen de la Victoria of Málaga/IBIMA and Dr. Ángel Guerrero-Zotano from the Instituto Valencia de Oncología
-
New#NewAseBioMember | “AseBio represents the meeting point of Spain’s biotechnology ecosystem...
Meet our new member, Genomcore. We spoke with Miquel A. Bru, Cofounder & CBDO.
-
NewKadans presents its new space for innovation in life sciences: Clesa Innovation Center
Located in the heart of biomedical innovation in Madrid, and with an investment of over 35 million euros and 18,000 m² of space dedicated to health research as well as scientific, social, and outreach
-
New#NewAseBioMember | “AseBio is a valuable platform for collaboration, visibility, and share...
Meet our new member, BioDuro. We spoke with Ricardo Inacio, Executive Director | Business Development EU.
-
NewSpain urges the EU to place biotechnology at the core of its Industrial Strategy
At AseBio, we strongly support the proposals put forward by the Minister of Industry and Tourism, which not only reflect the work and demands we have been advocating for, but also respond to many of
-
NewExpanding analyst interest in ORYZON
New U.S. investment bank joins, bringing total coverage to ten analysts.
-
-
NewEHDS: A revolution in health data management
It aims to turn health data into a strategic asset to improve healthcare, accelerate innovation in health technologies and empower European patients.
-
NewAseBio leads a key Work Package in the european ShapingBio project to drive innovation in ...
AseBio has played a leading role as the head of Work Package 3, “Testing and Implementation,” one of the core pillars of the project.
-
New#NewAseBioMember | “For us, AseBio is a key platform for connection, visibility, and colla...
Meet Maieutics Research Solutions, our new member. We talk with Lander Ezequiel Senderowicz, Operational Manager
-
NewORYZON continues to strengthen its patent portfolio for vafidemstat
New “Decision to grant” communications in Canada and Israel. For the treatment of aggression and social withdrawal
-
NewMaria Terrades: "Scientific knowledge, cutting-edge research and entrepreneurial vision c...
In 2024, the Parc Científic de Barcelona (PCB) reached full occupancy of its facilities and is preparing for a forthcoming expansion with two key projects: the refurbishment of the CUB building, which
-
New86 AseBio members working on new solutions to tackle the challenges of the Green Transitio...
The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the
-
Press release86 AseBio members working on new solutions to tackle the challenges of the Green Transitio...
The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the
-
NewNatac, part of the European OliWa project to reuse olive tree biomass
The initiative focuses on the transformation of this biomass into animal feed, functional additives, environmentally friendly packaging, and biogas
-
CompanyMAIEUTICS RESEARCH SOLUTIONS
-
EventVITAFOODS EUROPE 2026
-
NewNext-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro...
The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special focus on Ewing sarcoma.